Introduction {#s1}
============

The pituitary-derived gonadotropins, luteinizing hormone (LH) and follicle-stimulating hormone (FSH), are critical regulators of gonadal function and fertility in mammals. LH and FSH are dimeric glycoproteins composed of a common α subunit (αGSU or CGA) and unique β subunits (LHB and FSHB), which confer biological specificity. *Lhb* and *Fshb* expression, which is rate-limiting in the production of the mature hormones, is under the control of several endocrine, paracrine, and autocrine factors [@pone.0059058-Bernard1], [@pone.0059058-Jorgensen1]. Most important for *Lhb* production is gonadotropin-releasing hormone (GnRH). GnRH is released in a pulsatile manner by a small set of neurons within the preoptic area and mediobasal hypothalamus, binds the GnRH receptor (GnRHR) on gonadotrope cells of the anterior pituitary gland, and potently stimulates LH release and synthesis [@pone.0059058-Bliss1], [@pone.0059058-Gharib1]. LH in turn regulates steroidogenesis by the testes and ovaries, and is critical for ovulation and luteinization in females [@pone.0059058-Edson1], [@pone.0059058-Ma1].

Multiple factors control the cell-specific and hormone-induced expression of *Lhb* and *Fshb*. GnRH regulation of *Lhb* is mediated primarily through extracellular regulated kinases 1 and 2 (ERK1/2)-dependent induction of early-growth response 1 (EGR1) [@pone.0059058-Bliss2], [@pone.0059058-Liu1]. EGR1 then acts in concert with NR5A1 (also known as steroidogenic factor 1; SF1) and *paired-*like homeodomain transcription factor (PITX) proteins at conserved *cis*-elements within the proximal *Lhb* promoter to activate transcription (reviewed in [@pone.0059058-Jorgensen1]). How GnRH stimulates expression of *Fshb* is less well understood and may differ between species [@pone.0059058-Bernard1]. NR5A1\'s central role in gonadotrope function is perhaps most clearly demonstrated in mice with pituitary-specific deletion of *Nr5a1* [@pone.0059058-Zhao1], which display hypogonadotropic hypogonadism, with undetectable basal expression of *Lhb*, *Fshb*, and *Gnrhr*. Studies in cell lines implicate NR5A1 as a direct transcriptional regulator of all three of these genes, as well as *Cga* [@pone.0059058-Halvorson1], [@pone.0059058-Pincas1], [@pone.0059058-Fowkes1], [@pone.0059058-Jacobs1], [@pone.0059058-Barnhart1], [@pone.0059058-Duval1]. Nonetheless, *Nr5a1* knockout mice retain the ability to produce LH and FSH in response to exogenous GnRH stimulation [@pone.0059058-Zhao1], [@pone.0059058-Ikeda1]. These data suggest that NR5A1 is dispensable for GnRH-stimulated gonadotropin production or that another (perhaps related) factor might substitute for its absence. Consistent with the latter possibility, mutation of a conserved "gonadotrope-specific element" (GSE or NR5A1 binding site) in the bovine *Lhb* promoter abolishes its GnRH responsiveness in transgenic mice [@pone.0059058-Keri1]. Therefore, the available data collectively suggest a more important role for the GSE than for the NR5A1 protein itself in mediating the transcriptional response of the *Lhb* gene to GnRH.

NR5A2 (also known as liver receptor homolog 1; LRH-1) shares a high degree of sequence homology with NR5A1, binds the same consensus DNA sequence, and regulates many of the same genes [@pone.0059058-Fayard1], [@pone.0059058-Yazawa1]. Despite their functional overlap, global and cell-specific knockout studies in mice clearly show that the two proteins play distinct roles [@pone.0059058-Duggavathi1], [@pone.0059058-Pelusi1]. NR5A2 is expressed in adult murine pituitary gland and in immortalized gonadotrope-like cell lines, and can bind and activate the rat *Lhb* promoter *in vitro* [@pone.0059058-Zheng1], [@pone.0059058-Lo1]. Here, we investigated NR5A2\'s regulation of basal and GnRH-stimulated murine *Lhb* and *Fshb* transcription in immortalized cells and then ablated the gene specifically in gonadotropes in mice. Whereas NR5A2 is a potent regulator of gonadotropin β subunit promoter activities *in vitro*, it is dispensable for normal gonadotrope function and fertility *in vivo*.

Materials and Methods {#s2}
=====================

Reagents {#s2a}
--------

DMEM with 4.5 g/l glucose, l-glutamine and sodium pyruvate was from Wisent (St-Bruno, Quebec, Canada). Lipofectamine, Plus reagent, Lipofectamine 2000, gentamycin, fetal bovine serum (FBS) and SYBR green quantitative PCR master mix were purchased from Invitrogen (Burlington, Ontario, Canada). Anti-FLAG antibody (F7425) and chemicals were from Sigma (St. Louis, MO). Taq polymerase, T4 DNA ligase, restriction endonucleases, deoxynucleotide triphosphates and 5× Passive Lysis Buffer (PLB) were from Promega (Madison, WI). Goat anti-rabbit IgG-HRP conjugate (170--6515) was from Bio-Rad (Hercules, CA). Protease inhibitor tablets (Complete-Mini) were from Roche (Indianapolis, IN). ECL-plus reagent and protein markers were from GE Healthcare (Piscataway, NJ). Oligonucleotides were synthesized by Integrated DNA Technologies (Coralville, IA). siRNAs for *Nr5a1* (D-051262-01; previously described and validated in [@pone.0059058-Fortin1]) and *Nr5a2* (siRNA \#1: D-047044-03; siRNA\#2: D-047044-04) were obtained from Dharmacon (Lafayette, CO).

Cell culture, reporter assays, and western blot {#s2b}
-----------------------------------------------

LβT2 cells ([@pone.0059058-Alarid1]; gift from Dr. P. Mellon, University of California, San Diego) and CHO cells (ATCC CCL-61; gift from Dr. P. Morris, Population Council, New York, NY) were cultured as previously described [@pone.0059058-Bernard2], [@pone.0059058-Lamba1]. For reporter assays, LβT2 cells were seeded at 3×10^5^ cells per well in 48-well plates three days before transfection with Lipofectamine 2000. HeLa cells (ATCC CCL-2; gift from Dr J. Tanny, McGill University, Montréal) were cultured in DMEM supplemented with 10% FBS, and plated at 1.8×10^4^ cells per well in 48-well plate for reporter assays. Cells were transfected the next day using Lipofectamine 2000. Reporter assays were performed as previously described [@pone.0059058-Wang1]. For western blots, CHO cells in 10-cm dishes were transfected using Lipofectamine following the manufacturer\'s instructions. Whole cell lysates were prepared and analyzed as described [@pone.0059058-Bernard2].

Plasmids {#s2c}
--------

The murine −232/+5 *Lhb*-luc and −1990/+1 *Fshb*-luc reporters, as well as the EGR1, NR5A1 and PITX1 expression vectors were described previously [@pone.0059058-Fortin1], [@pone.0059058-Bernard2], [@pone.0059058-Fortin2], [@pone.0059058-Lamba2]. The murine −1772/+38 *Gnrhr*-luc reporter was a gift from Colin Clay (Colorado State University, Fort Collins, CO). The full-length and short isoform (variant \#2) NR5A2 expression vectors were produced by PCR amplification from full-length NR5A2 in pCMX [@pone.0059058-Fayard2] and sub-cloned in the *EcoR*I and *Xba*I sites of pcDNA3.0. The same strategy was used for generation of FLAG-tagged NR5A2 constructs, except that the forward primers replaced the translation initiation codon (ATG) with CGA, and the products were cloned in-frame downstream of a FLAG tag in pcDNA3.0 [@pone.0059058-Lamba2]. Mutant reporters and expression vectors were produced by site-directed mutagenesis following the QuikChange protocol (Stratagene).

5′ rapid amplification of cDNA ends (RACE) {#s2d}
------------------------------------------

5′RACE was performed using the FirstChoice RLM-RACE kit (Ambion, Austin, TX), following the manufacturer\'s protocol. Briefly, following 5′ RACE adapter ligation to decapped total murine pituitary RNA, first-strand cDNA synthesis was performed using an *Nr5a2* gene-specific primer in exon 3. Two rounds of nested PCR were performed using forward primers in the 5′RACE adapter and reverse gene-specific primers in exon 3 of *Nr5a2*. PCR products were cloned in pGEM-T Easy (Promega, Madison, WI) and sequenced (GenomeQuébec, Montréal).

Animals {#s2e}
-------

*Nr5a2^fl/fl^*, *Gnrhr^GRIC/+^,* and *ROSA26^eYFP/+^* mice were described previously [@pone.0059058-Coste1], [@pone.0059058-Srinivas1], [@pone.0059058-Wen1]. To generate gonadotrope-specific *Nr5a2* knockout and control animals, *Nr5a2^fl/fl^;Gnrhr^+/+^* mice were bred with *Nr5a2^+/+^*;*Gnrhr^GRIC/GRIC^* mice. Resulting *Nr5a2^fl/+^;Gnrhr^GRIC/+^* females were crossed to *Nr5a2^fl/fl^; Gnrhr^+/+^* males to generate littermates with the experimental (*Nr5a2^fl/fl^*;*Gnrhr^GRIC/+^*) and control (*Nr5a2^fl/fl^*; *Gnrhr^+/+^*) genotypes. *Gnrhr^GRIC/+;^ROSA26^eYFP/+^* mice were generated by crossing *Gnrhr^GRIC/GRIC^;ROSA26^+/+^* females with *Gnrhr^+/+^;ROSA26^eYFP/eYFP^* males. *Nr5a2^fl/fl^;Gnrhr^GRIC/+^;ROSA26^eYFP/+^* were generated by crossing *Nr5a2^fl/fl^;Gnrhr^GRIC/+^;ROSA26^+/+^* females with *Nr5a2^fl/fl^;Gnrhr^+/+^;ROSA26^eYFP/eYFP^* males. Genotyping primers are listed in [Table S1](#pone.0059058.s007){ref-type="supplementary-material"}. For mating studies, 8 week-old experimental and control male or female mice were individually paired with a single adult C57BL6 mouse of the opposite sex, and fertility was evaluated over a period of six months. The presence of newborn mice was monitored daily starting from 20 days after pairing. Pups were counted immediately after birth. For tissue and blood collection, six-week old animals were used. All animal experiments were performed in accordance with institutional and federal guidelines and approved by the McGill University IACUC and the Comité d\'Éthique de l\'Utilisation des Animaux of the Université de Montréal.

FACS sorting of primary gonadotrope cells {#s2f}
-----------------------------------------

For gonadotrope purification, adult (\>6 week-old) male and female *Nr5a2^fl/fl^;Gnrhr^GRIC/+^;ROSA26^eYFP/+^* and *Gnrhr^GRIC/+^;ROSA26^eYFP/+^* mice were sacrificed by CO~2~ asphyxiation. Dissected pituitaries were collected in M199 media containing 10% FBS, washed three times in HBSS, and minced with a scalpel in a Petri dish. Minced pituitaries were digested in 1.5 mg/mL collagenase (Sigma \#C-0130; diluted in Hank\'s Balanced Salt Solution HBSS with 30 mg/mL BSA, pH 7.4) at 37°C for 2 h with gentle stirring (40 μL/pituitary). The tissue suspension was then washed with 10 mL calcium-free HBSS, centrifuged for 5 min at 1200× g, and resuspended in pancreatin solution (Sigma P3292; 4.5 mg/mL in calcium-free HBSS; 40 μL/pituitary). Pancreatin digestion was performed in a 37°C water bath with manual agitation for 15 min. The resulting cell suspension was washed three times in 10 mL M-199 media supplemented with 10% FBS, with centrifugation steps between each wash as above, and filtered with a 40 micron nylon mesh. The final cell pellet was resuspended in 1 mL M-199 media, and the cells sorted using a FACSAria cell sorter. Both YFP-positive (i.e., gonadotropes) and YFP-negative (i.e., non-gonadotropes) were used in subsequent analyses.

RNA extraction, cDNA synthesis and qPCR {#s2g}
---------------------------------------

Total RNA was extracted from cells (Allprep DNA/RNA, Qiagen) or tissues (TRIzol, Invitrogen), following the manufacturer\'s instructions. cDNA was prepared as previously described [@pone.0059058-Bernard2]. Quantitative PCR (qPCR) was performed using the Platinum SYBR Green qPCR SuperMix-UDG (Invitrogen) on a Corbett Rotor-Gene 6000 instrument. Samples were assayed in duplicate or triplicate, and analyzed using the 2^−ΔΔCt^ method [@pone.0059058-Livak1]. qPCR primers are listed in [Table S1](#pone.0059058.s007){ref-type="supplementary-material"}.

Hormone assays {#s2h}
--------------

For serum collection, mice were killed by CO~2~ asphyxiation, and blood obtained by cardiac puncture. The blood was left to clot for 15 minutes at room temperature, and then spun at 3000 rpm for 10 minutes for serum isolation. Serum LH and FSH were measured using the mouse/rat LH/FSH multiplex assay at the Ligand Assay and Analysis Core of the University of Virginia Center for Research in Reproduction.

Statistical analysis {#s2i}
--------------------

Data from the cell culture experiments were analyzed using one- or two-way ANOVA, with Tukey post-hoc test to assess differences between groups. For all the reporter experiments, "N" is equal to the number of experiments. In some reporter experiments, data were log-transformed when variances were unequal between groups. Data from the animal experiments were analyzed using independent t-tests. *P*-values \<0.05 were considered statistically significant.

Results {#s3}
=======

A short Nr5a2 mRNA isoform is expressed in the murine pituitary gland {#s3a}
---------------------------------------------------------------------

Because previous results indicated that NR5A2 from whole pituitary or gonadotrope-like cell lines migrated faster than *in vitro* translated full-length (liver-derived) NR5A2 in western blots [@pone.0059058-Zheng1], we first mapped the transcription start site of *Nr5a2* in murine pituitary by 5′ rapid amplification of cDNA ends (5′ RACE). Analyses of several independent clones indicated that transcription is initiated in the second intron, 217 base pairs (bp) upstream of the third exon ([Fig. 1A](#pone-0059058-g001){ref-type="fig"}; GenBank acc. \# JX648197). The resulting mRNA likely utilizes the previously described start of translation in exon 3 [@pone.0059058-Galarneau1], producing an isoform lacking the N-terminal 61 amino acids of the full-length protein, which constitutes most of the AF1 domain ("NR5A2 variant \#2", CCDS acc. \# NP_001153241). To confirm the 5′ RACE results, murine liver and pituitary cDNAs were analyzed by PCR using a reverse primer in exon 6 and forward primers in exons 2, 3, 4, or 5. Whereas a product was detected with all primer pairs using liver cDNA, no product was obtained from pituitary cDNA with the forward primer in exon 2, confirming that pituitary transcripts lack this exon ([Fig. 1B](#pone-0059058-g001){ref-type="fig"}). In subsequent experiments, we used an expression vector encoding the pituitary NR5A2 isoform.

![Characterization of a pituitary-specific *Nr5a2* mRNA isoform.\
**A**) Schematic representation of the *Nr5a2* locus, *Nr5a2* mRNA isoforms, and the resulting protein products. Black boxes indicate coding exons; white boxes indicate non-coding sequences. The asterisk (\*) after exon 3 denotes the fact that it comes in two forms: the shorter, canonical form (denoted in black) first described in isoforms 1 and 2, and a 5′-extended form (denoted by the gray extension at the 5′ end) expressed in the pituitary (as mapped by 5′RACE in this study). Arrows indicate the alternative translation start sites in exons 1 and 3. AF-1, activation function 1; DBD, DNA-binding domain; Ftz, *fushi tarazu* F1-like box; LBD, ligand-binding domain; AF-2, activation function 2. **B**) PCR analysis of cDNA prepared from murine liver and pituitary. A common antisense primer in *Nr5a2* exon 6 was used in all the reactions. Sense primers were located in exon 2, 3, 4 or 5 as indicated. Amplification of *Rpl19* was used as a positive control for cDNA integrity.](pone.0059058.g001){#pone-0059058-g001}

NR5A2 activates the murine Lhb promoter {#s3b}
---------------------------------------

To determine whether NR5A2 can induce murine *Lhb* transcription, we examined the effect of ectopic NR5A2 expression on transcriptional activity of the proximal murine *Lhb* promoter in heterologous HeLa cells. NR5A2 robustly induced the murine -232/+5 *Lhb*-luc reporter ([Fig. 2A](#pone-0059058-g002){ref-type="fig"}) and did so to a similar extent as NR5A1 ([Fig. 2B](#pone-0059058-g002){ref-type="fig"}). NR5A1 cooperatively activates the *LHB*/*Lhb* promoter with early-growth response 1 (EGR1) and *paired*-like homeodomain (PITX) transcription factors [@pone.0059058-Halvorson1], [@pone.0059058-Fortin1], [@pone.0059058-Dorn1], [@pone.0059058-Halvorson2], [@pone.0059058-Kaiser1], [@pone.0059058-Tremblay1]. To assess whether NR5A2 can mediate similar functional interactions, we examined the effect of ectopically expressed NR5A1 or NR5A2 in combination with EGR1 and/or PITX1 on transcriptional activity of the murine *Lhb*-luc reporter in HeLa cells. All four factors individually activated the *Lhb* promoter, and EGR1 synergized with PITX1 ([Fig. 2A--B](#pone-0059058-g002){ref-type="fig"}). Furthermore, both NR5A1 and NR5A2: 1) synergized with EGR1, 2) had no significant effect on PITX1-mediated transcription, and 3) did not further amplify the synergism between EGR1 and PITX1 ([Fig. 2A--B](#pone-0059058-g002){ref-type="fig"}). Therefore, NR5A1 and NR5A2 produced indistinguishable functional interactions with EGR1 and PITX1 on the murine *Lhb* promoter in heterologous cells.

![Activation of the murine *Lhb* promoter by NR5A2.\
HeLa cells were transfected with 225 ng/well of the murine −232/+5 *Lhb*-luc reporter as well as 50 ng/well of EGR1 and/or PITX1 expression constructs and 50 ng/well of **A**) NR5A2 (pituitary isoform) or **B**) NR5A1 expression vectors (black bars) or empty vector (pcDNA3 -- white bars). Bars with different symbols differ significantly. Data represent the mean + SEM of four (**A**) or five (**B**) independent experiments performed in triplicate.](pone.0059058.g002){#pone-0059058-g002}

Activation of the *LHB*/*Lhb* promoter by NR5A1 requires two conserved response elements (GSEs at −128/−121 and −66/−59 relative to the transcription start site in mouse), which neighbor adjacent EGR1 and PITX binding sites in the proximal promoter ([@pone.0059058-Halvorson1], [@pone.0059058-Keri1], [@pone.0059058-Fortin1], [@pone.0059058-Dorn1], [@pone.0059058-Halvorson2], [@pone.0059058-Kaiser1], [@pone.0059058-Tremblay1]; [Fig. 3A](#pone-0059058-g003){ref-type="fig"}). Because NR5A1 and NR5A2 share identical consensus DNA binding sites, we examined whether the NR5A2 response was also mediated through these two GSEs. To this end, we assessed the effect of ectopic NR5A2 expression on murine −232/+5 *Lhb* promoter-reporters lacking the distal, proximal, or both GSEs. Mutation of either one or both elements abolished induction of the promoter by NR5A1 or NR5A2 ([Fig. 3B--C](#pone-0059058-g003){ref-type="fig"} and Fig. S1).

![NR5A2 activate the murine *Lhb* promoter through conserved *GSE* elements.\
**A**) Alignment of the proximal *LHB*/*Lhb* promoters from human, mouse, rat and cow. Bases are numbered relative to the transcriptional start site (+1; not shown). The conserved GSE, *EGR* and *PITX* response elements are boxed. Nucleotides that differ between the species are shaded. **B**) and **C**) HeLa cells were transfected with 225 ng/well of the murine −232/+5 *Lhb*-luc reporter or the same reporter carrying a mutation in both GSE elements (*GSEmut*), along with 50 ng/well of **B**) NR5A2 (pituitary isoform) or **C**) NR5A1 expression vectors (black bars) or empty vector (pcDNA3 -- white bars). Bars with different symbols differ significantly. Data represent the mean + SEM of five (**B**) and four (**C**) independent experiments performed in triplicate.](pone.0059058.g003){#pone-0059058-g003}

Two putative GSEs (−341/−333 and −239/−231) in the murine *Fshb* promoter were previously shown to regulate basal promoter activity in cooperation with NF-Y binding sites [@pone.0059058-Jacobs1]. However, direct actions of NR5A1 on *Fshb* transcription via these (or other) *cis*-elements were not demonstrated. Therefore, we examined the ability of NR5A1 or NR5A2 to induce the murine −1990/+1 *Fshb*-luc reporter in HeLa cells. Unlike the case with the *Lhb* reporter, neither NR5A1 nor NR5A2 activated *Fshb* promoter activity ([Fig. S2](#pone.0059058.s002){ref-type="supplementary-material"}). Co-expression of NR5A1 or NR5A2 with PITX1 also failed to stimulate the *Fshb* promoter (data not shown).

Endogenous NR5A2 regulates basal and GnRH-induced Lhb and Fshb promoter activities in LβT2 cells {#s3c}
------------------------------------------------------------------------------------------------

Next, we evaluated the role of endogenous NR5A1 or NR5A2 in basal and GnRH-stimulated transcriptional activity of the murine *Lhb* and *Fshb* promoters in homologous LβT2 cells. We co-transfected cells with the murine −232/+5 *Lhb*-luc reporter and short interfering RNAs (siRNAs) directed at *Nr5a1*, *Nr5a2* (isoform \#2), or with a control siRNA, and stimulated with GnRH. *Nr5a1* and *Nr5a2* siRNAs significantly decreased basal and GnRH-stimulated promoter activity ([Fig. 4A--B](#pone-0059058-g004){ref-type="fig"}). The efficiency and sequence specificity of the siRNAs was verified in control experiments ([Fig. S3](#pone.0059058.s003){ref-type="supplementary-material"}A and Ref. [@pone.0059058-Fortin1]). In addition, one *Nr5a2* siRNA, which displayed poor efficiency at knocking down NR5A2 (siRNA \#2), did not affect GnRH-stimulated promoter activity ([Fig. S3](#pone.0059058.s003){ref-type="supplementary-material"}B--C).

![Endogenous NR5A2 regulates *Lhb* and *Fshb* promoter activity in immortalized gonadotropes.\
LβT2 cells were transfected with 225 ng/well of the following reporters: **A**) and **B**) murine −232/+5 *Lhb*-luc; **C**) and **D**) murine −1990/+1 *Fshb*-luc. Cells were co-transfected with the following siRNAs, at a final concentration of 5×10^−9^ M: **A**) and **C**) *Nr5a2*; **B**) and **D**) *Nr5a1*. In all cases, a non-specific siRNA, added at a final concentration of 5×10^−9^ M, was used as control. Cells were treated with 10^−7^ M GnRH for 6 h (black bars) or left untreated (white bars) prior to collection of whole cell lysates for luciferase assays. Bars with different symbols differ significantly. Data represent the mean +SEM of three (**A**, **B**, **D**), or seven (**C**) independent experiments performed in triplicate.](pone.0059058.g004){#pone-0059058-g004}

Although ectopically expressed NR5A1 or NR5A2 failed to activate *Fshb* promoter activity in heterologous HeLa cells ([Fig. S2](#pone.0059058.s002){ref-type="supplementary-material"}), we examined the effect of depleting endogenous NR5A1 or NR5A2 on the activity of the murine −1990/+1 *Fshb*-luc reporter in LβT2 cells. Similar to the *Lhb* promoter, both the *Nr5a1* and *Nr5a2* siRNAs significantly decreased basal and GnRH-stimulated activation of the −1990/+1 *Fshb* promoter ([Fig. 4C--D](#pone-0059058-g004){ref-type="fig"}). As observed with the *Lhb* promoter, *Nr5a2* siRNA \#2 did not significantly impair GnRH stimulation of the *Fshb* promoter ([Fig. S3](#pone.0059058.s003){ref-type="supplementary-material"}D).

Generation of gonadotrope-specific Nr5a2 knockout mice {#s3d}
------------------------------------------------------

The *in vitro* data above show that NR5A2 is expressed in pituitary and functions similarly to NR5A1 with respect to *Lhb* promoter activity. To test whether NR5A2, like NR5A1, plays an essential role in gonadotropin synthesis and fertility *in vivo*, we generated mice with a gonadotrope-specific deletion of *Nr5a2* by crossing *Gnrhr^GRIC^* mice with *Nr5a2^fl/fl^* mice. As loxP sites flank exons 4 and 5 in this *Nr5a2* allele, these mice are expected to lack both the full-length and shorter NR5A2 isoforms. Recombination of the *Nr5a2* gene was only observed in pituitary gland and in testes ([Fig. 5A](#pone-0059058-g005){ref-type="fig"}), as expected from the previously described expression pattern of Cre recombinase in *Gnrhr^GRIC^* mice [@pone.0059058-Wen2]. To assess the efficiency of recombination of *Nr5a2* in our model, we bred the *ROSA26^eYFP^* reporter allele [@pone.0059058-Srinivas1] into the *Nr5a2^fl/fl^*;*Gnrhr^GRIC/+^* background. In the resulting mice, expression of Cre recombinase in gonadotropes results in the simultaneous deletion of the *Nr5a2* gene and expression of YFP. We purified gonadotropes (YFP + cells) from *Nr5a2^fl/fl^*;*Gnrhr^GRIC/+^*;*ROSA26^eYFP/+^* mice by FACS ([Fig. S4](#pone.0059058.s004){ref-type="supplementary-material"}) and examined the extent of *Nr5a2* recombination by PCR. YFP + cells showed the expected PCR product for the recombined allele, indicating the near complete deletion of *Nr5a2* in those cells ([Fig. 5B](#pone-0059058-g005){ref-type="fig"}). By comparison, cells in the YFP- fraction only showed a band corresponding to the "floxed" (non-recombined) *Nr5a2* allele. Therefore, *Nr5a2* was efficiently and specifically recombined in gonadotropes in our model.

![Generation and validation of gonadotrope-specific *Nr5a2* knockout mice.\
**A**) Genomic DNA was extracted from the indicated tissues of *Nr5a2^fl/fl^* (control) and *Nr5a2^fl/fl^*; *Gnrhr^GRIC/+^* (*Nr5a2KO*) mice and analyzed by PCR for the presence of the floxed ("flox" -- lower band) or recombined ("rec" -- upper band) *Nr5a2* alleles. **B**) Pituitary cells from *Gnrhr^GRIC/+^*;*ROSA26^eYFP/+^* (control) and *Nr5a2^fl/fl^*;*Gnrhr^GRIC/+^*;*ROSA26^eYFP/+^* (*Nr5a2*KO) mice were sorted by FACS, and genomic DNA was extracted from the YFP-positive (+) and YFP-negative (−) fractions. Genotyping PCR was performed to detect the presence of the wild-type ("WT"), "floxed" ("flox") and "recombined" ("rec") *Nr5a2* alleles.](pone.0059058.g005){#pone-0059058-g005}

Normal gonadotropin synthesis and fertility in gonadotrope-specific Nr5a2 knockout mice {#s3e}
---------------------------------------------------------------------------------------

As our *in vitro* data suggested a role for NR5A2 in the regulation of both *Lhb* and *Fshb* transcription, we examined the expression of these genes in the pituitaries of 6 week-old *Nr5a2^fl/fl^*; *Gnrhr^GRIC/+^* (hereafter *Nr5a2*KO) mice and *Nr5a2^fl/fl^* (hereafter "control") littermates. These analyses revealed no significant difference in the expression of either *Lhb* or *Fshb* between genotypes, both in males and females ([Fig. 6A--B](#pone-0059058-g006){ref-type="fig"}). Accordingly, serum levels of FSH were normal in *Nr5a2*KO male and female mice, whereas LH levels were highly variable and often undetectable in mice of both sexes and genotypes ([Fig. 6C](#pone-0059058-g006){ref-type="fig"} and data not shown). Next, we assessed reproductive function in *Nr5a2*KO mice by monitoring the fertility of males and females after pairing with wild-type C57BL/6 control mice over a period of 6 months. These studies revealed normal fertility in *Nr5a2*KO mice, as neither males nor females differed from controls in terms of mean litter size, inter-litter interval, latency to first litter, or cumulative number of pups produced over the duration of the mating trial ([Table 1](#pone-0059058-t001){ref-type="table"}). Finally, we examined gonads and accessory sex organs in *Nr5a2*KO mice (testes and seminal vesicles in males; ovaries and uteri in females). All of the examined tissues were normal in appearance (data not shown) in *Nr5a2*KO mice and did not differ in weight relative to controls ([Fig. S5](#pone.0059058.s005){ref-type="supplementary-material"}). Collectively, these results indicate that the activity of the reproductive axis and the production of gonadotropins are intact in gonadotrope-specific *Nr5a2* knockout mice.

![Normal gonadotropin synthesis in gonadotrope-specific *Nr5a2* knockout mice.\
cDNA was prepared from total RNA isolated from individual pituitary glands of *Nr5a2^fl/fl^* (control) and *Nr5a2^fl/fl^*;*Gnrhr^GRIC/+^* (*Nr5a2*KO) mice, and analyzed for expression of **A**) *Lhb* and **B**) *Fshb* by quantitative real-time PCR. The amount of *Lhb* and *Fshb* transcripts was normalized to the expression of the housekeeping gene *Rpl19*. For **A**) and **B**), n = 6 for control and n = 7 for *Nr5a2*KO mice, for both males and females. **C**) Serum FSH levels were measured in 6-week old male (control, n = 5; *Nr5a2*KO, n = 7) and female (control, n = 4; *Nr5a2*KO, n = 6) mice.](pone.0059058.g006){#pone-0059058-g006}

10.1371/journal.pone.0059058.t001

###### Fertility data.

![](pone.0059058.t001){#pone-0059058-t001-1}

  Genotype       N   Days to first litter   Mean litter size   Average number of pups   Inter-litter interval (days)
  ------------- --- ---------------------- ------------------ ------------------------ ------------------------------
  **males**                                                                            
  *Control*      5         26.2±5.2             5.3±0.2               24.4±3.8                    30.8±2.5
  *Nr5a2*KO      5         31.2±4.2             6.1±0.6               33.0±3.6                    27.0±2.2
  **females**                                                                          
  *Control*      5         26.2±1.3             7.3±0.4               40.8±3.2                    29.2±0.7
  *Nr5a2*KO      7         26.4±6.9             6.6±0.7               38.1±2.8                    25.6±1.9

Mice of the indicated genotypes were individually paired with control (C57BL6) mice of the opposite sex for a period of 6 months, and fertility parameters were recorded. Data represent mean ± SEM.

Nr5a2 is expressed at low levels in murine gonadotropes {#s3f}
-------------------------------------------------------

Though our 5′ RACE results demonstrated *Nr5a2* mRNA expression in whole pituitary, the absence of a reproductive phenotype in gonadotrope-specific *Nr5a2* knockout mice led us to ask whether the gene is actually expressed in gonadotropes. We first attempted to localize the NR5A2 protein in adult pituitary by immunohistochemistry or immunofluorescence, but were unable to produce consistent results (data not shown). Therefore, we focused on mRNA expression. We developed qPCR assays using previously validated primers [@pone.0059058-Coste1] as well as primers within the exons 4 and 5, which are deleted upon recombination in *Nr5a2* floxed mice. *Nr5a2* is robustly expressed in liver and ovary and we confirmed these observations with both primer sets and total RNA extracted from these tissues in wild-type mice ([Fig. 7A](#pone-0059058-g007){ref-type="fig"}). In whole pituitary, *Nr5a2* was expressed at only 0.6% the level observed in ovary ([Fig. 7A](#pone-0059058-g007){ref-type="fig"}). Using the same cDNA samples, we readily detected *Nr5a1* in ovary and pituitary, but not liver ([Fig. 7A](#pone-0059058-g007){ref-type="fig"}). To more directly assess expression in gonadotropes, we purified cells from *Gnrhr^GRIC/+^;ROSA26^eYFP/+^* (control) and *Nr5a2^fl/fl^;Gnrhr^GRIC/+^;ROSA26^eYFP/+^* (*Nr5a2* KO). Whereas *Nr5a1* mRNA was enriched in YFP + (i.e., gonadotropes) relative to YFP- (i.e., non-gonadotropes) cells, *Nr5a2* was uniformly low in both cell populations in both the control and knockout genotypes ([Fig. 7B](#pone-0059058-g007){ref-type="fig"}). In fact, the levels were so low as to preclude a reliable assessment of the extent of mRNA depletion in knockouts. That said, our analysis of DNA from the same purified cells clearly shows how efficiently the floxed allele was recombined ([Fig. 5B](#pone-0059058-g005){ref-type="fig"}). Collectively, these data suggest that *Nr5a2* is expressed at very low levels in gonadotropes *in vivo*.

![*Nr5a2* is expressed at low levels in gonadotropes.\
**A**) cDNA was prepared from total RNA isolated from the indicated tissues from wild-type mice, and analyzed for the expression of *Nr5a1* or *Nr5a2*. Two different primer sets were used for Nr5a2, with the first using a forward primer in exon 4 and a reverse primer in exon 5 (ex 4--5) and the second with a forward primer in exon 6 and a reverse primer in exon 8 (ex 6--8). **B**) cDNA was prepared from total RNA isolated from sorted cells from *Gnrhr^GRIC/+^*;*ROSA26^eYFP/+^* mice (C-YFP-: YFP-negative cells ; C-YFP +: YFP-positive cells; C = control), *Nr5a2^fl/fl^*;*Gnrhr^GRIC/+^*;*ROSA26^eYFP/+^* mice (KO-YFP-: YFP-negative cells; KO-YFP+: YFP-positive cells; KO = knockout), or wild-type mouse ovary. Expression of *Nr5a1* and *Nr5a2* (exon 6--8 primer set) was assessed by qPCR, and normalized to the expression of the housekeeping gene *Rpl19*. In both panels, the results for ovary were normalized to 1 for each primer set and the values for other tissues or isolated cells presented relative to ovary.](pone.0059058.g007){#pone-0059058-g007}

Discussion {#s4}
==========

Here, we characterized the role of NR5A2 in gonadotropin subunit expression *in vitro* and *in vivo*. We identified a novel, pituitary-specific *Nr5a2* mRNA isoform in murine pituitary gland. The encoded NR5A2 protein lacks the first 61 N-terminal amino acids of the full-length (canonical) protein, thus truncating most of its "activator function 1" (AF-1) domain. In contrast to other nuclear receptors, no specific function has been ascribed to this domain in NR5A2, and all NR5A2 co-regulators characterized to date interact via its C-terminal AF-2 region [@pone.0059058-Fayard1], [@pone.0059058-Lazarus1]. Accordingly, we observe that the full-length and pituitary NR5A2 isoforms are functionally indistinguishable in their abilities to activate the murine *Lhb* promoter (data not shown) and do so to an extent and in a manner comparable to NR5A1. Indeed, the NR5A2 response is mediated through the same proximal promoter *cis*-elements (GSEs) used by NR5A1 [@pone.0059058-Halvorson1], [@pone.0059058-Fortin1], [@pone.0059058-Dorn1], [@pone.0059058-Halvorson2], [@pone.0059058-Kaiser1], [@pone.0059058-Tremblay1]. Furthermore, NR5A2 functionally interacts with other well-characterized transcriptional regulators of *Lhb*, EGR1 and PITX1 [@pone.0059058-Jorgensen1], [@pone.0059058-Fortin1], [@pone.0059058-Tremblay1], [@pone.0059058-Quirk1], in an identical manner to NR5A1. By knockdown experiments in the LβT2 murine gonadotrope-like cell line, we also show that endogenous NR5A2 regulates both basal and GnRH-stimulated *Lhb* promoter activation. However, the effect of NR5A1 depletion is more dramatic than that of NR5A2. At least part of the difference might be attributable to the relative roles of NR5A1 and NR5A2 in GnRH receptor expression. Whereas *Nr5a1* knockdown significantly impairs *Gnrhr* promoter-reporter activity, *Nr5a2* siRNAs has little to no effect ([Fig. S6](#pone.0059058.s006){ref-type="supplementary-material"}A). Similarly, whereas *Gnrhr* mRNA levels are significantly depleted in pituitaries of *Nr5a1* knockout mice [@pone.0059058-Zhao1], *Gnrhr* expression is normal in our *Nr5a2*KO animals ([Fig. S6](#pone.0059058.s006){ref-type="supplementary-material"}B). These data suggest that NR5A1 and NR5A2 play similar, though not identical roles in gonadotrope-like cells.

The data also show that depletion of either NR5A1 or NR5A2 in LβT2 cells substantially impairs basal and GnRH-stimulated murine *Fshb* promoter-reporter activity. Exactly how NR5A1 and/or NR5A2 regulate *Fshb* expression is presently unclear. Although previous work suggested a requirement for putative NR5A1 binding sites within the proximal promoter for basal *Fshb* reporter activity [@pone.0059058-Jacobs1], a role for the NR5A1 protein itself was not demonstrated in that study. Further, it was previously reported that NR5A1 does not activate the bovine *Fshb* promoter by itself [@pone.0059058-Tremblay2]. In our hands, neither NR5A1 nor NR5A2 induce murine *Fshb* promoter-reporter activity when ectopically expressed in heterologous reporter assays. However, the dramatic loss of *Fshb* mRNA and FSH protein in gonadotropes of pituitary-specific *Nr5a1* knockout mice [@pone.0059058-Zhao1] certainly suggests a role, either direct or indirect, for NR5A1 in *Fshb* expression.

Our findings in heterologous and gonadotrope-like cell lines prompted us to investigate the role of NR5A2 in gonadotrope function *in vivo*. To this end, we generated and analyzed gonadotrope-specific *Nr5a2* knockout (*Nr5a2*KO) mice. We confirm the efficient recombination of the *Nr5a2* gene in gonadotropes, in good agreement with the previously demonstrated efficiency and specificity of the *Gnrhr^GRIC^* allele we used to target Cre expression [@pone.0059058-Wen1], [@pone.0059058-Wen2], [@pone.0059058-Tran1] Nonetheless, *Nr5a2*KO mice show normal *Lhb* and *Fshb* mRNA expression and circulating gonadotropin levels, and are fertile. Though expressed and functional in LβT2 cells, *Nr5a2* mRNA levels are extremely low in actual adult gonadotropes. Thus, the most likely explanation for our results is that, among NR5A family members, NR5A1 (which is maintained at normal levels in our mice), but not NR5A2 is the major regulator of gonadotropin synthesis *in vivo*.

In summary, we provide *in vitro* evidence that NR5A2 can mediate transcriptional activation of the murine *Lhb* and *Fshb* promoters by GnRH. Moreover, NR5A2 appears to regulate *Lhb* transcription in a manner analogous to NR5A1. However, unlike the case in *Nr5a1*-deficient mice, gonadotrope-specific *Nr5a2*KO animals exhibit normal gonadotropin subunit expression and reproductive function. These observations underscore the importance of *in vivo* validation of models developed exclusively in immortalized cell lines.

Supporting Information {#s5}
======================

###### 

**Both conserved GSE elements mediate NR5A2 activation of the murine** ***Lhb*** **promoter.** HeLa cells were transfected with 225 ng/well of the murine −232/+5 *Lhb*-luc reporter or the same reporter carrying a mutation in the proximal (*pGSEmut*) or distal (*dGSEmut*) GSE elements along with 50 ng/well of **A**) NR5A2 (pituitary isoform) or **B**) NR5A1 expression vectors (black bars) or empty vector (pcDNA3 -- white bars). Bars with different symbols differ significantly. Data represent the mean +SEM of five (**A**) and four (**B**) independent experiments performed in triplicate. Note that these data are from the same experiments as those shown in [Figure 3](#pone-0059058-g003){ref-type="fig"}. Therefore, the values for the wild-type (WT) reporter are the same in both figures.

(TIF)

###### 

Click here for additional data file.

###### 

**NR5A1 and NR5A2 do not directly activate the murine** ***Fshb*** **promoter.** HeLa cells were transfected with 225 ng/well of the murine −232/+5 *Lhb*-luc or −1990/+1 *Fshb*-luc reporter as well as 50 ng/well of **A**) NR5A2 or **B**) NR5A1 (pituitary isoform) expression vectors or empty vector (pcDNA3). Bars with different symbols differ significantly. Data represent the mean + SEM of three independent experiments performed in triplicate.

(TIF)

###### 

Click here for additional data file.

###### 

**Validation of the** ***Nr5a2*** **siRNAs used in this study. A**) and **B**) CHO cells were transfected with wild-type (WT) or siRNA-resistant (Res.) forms of Flag-tagged NR5A2 along with 5×10−9 M non-specific (control) or *Nr5a2* siRNAs, or 1X siRNA dilution buffer. Whole-cell lysates were collected and subjected to anti-Flag (top panel) or anti-β-actin (bottom panel) western blot analyses. **C**) and **D**) LβT2 cells were transfected with 225 ng/well **C**) murine −232/+5 *Lhb*-luc or **D**) murine −1990/+1 *Fshb*-luc reporters. Cells were co-transfected with *Nr5a2* siRNA \#2, or a non-specific siRNA (control) at a final concentration of 5×10−9 M. Cells were treated with 10−7 M GnRH for 6 h (black bars) or left untreated (white bars) prior to collection of whole cell lysates for luciferase assays. Bars with different symbols differ significantly. Data represent the mean +SEM of three (**C**), or seven (**D**) independent experiments performed in triplicate. The data presented in panels **C** and **D** of this figure are from the same experiments as those of [Figure **4A and 4C**](#pone-0059058-g004){ref-type="fig"}, respectively. Therefore, the values for the "control" siRNA condition in the two figures are the same.

(TIF)

###### 

Click here for additional data file.

###### 

**Efficient and selective purification of YFP + gonadotropes from** ***Gnrhr^GRIC^*** ^**/+**^ **;** ***ROSA26^eYFP^*** ^**/+**^ **mice.** Dissociated pituitary cells from wild-type (**A,** ***a***) and *Gnrhr^GRIC^*/+;*ROSA26^eYFP^*/+ mice (**B, b--D, d**) were plated in primary culture. **A--D**) Pictures of cells taken under brightfield illumination. **a--d**) The same cells as in **A--D**, but viewed under fluorescent illumination for detection of YFP. **B, b**) Cells from GnrhrGRIC/+; *ROSA26^eYFP^*/+ mice prior to FACS. **C, c**) Cells from the YFP + fraction following FACS. **D, d**) Cells from the YFP- fraction following FACS. A field with a single YFP + cell is shown, but most fields examined lacked YFP + cells.

(TIF)

###### 

Click here for additional data file.

###### 

**Reproductive organ weights in gonadotrope-specific** ***Nr5a2*** **knockout mice.** Ovarian (**A**) and uterine (**B**) weights were measured in 6 week-old female *Nr5a2^fl/fl^* (control, n = 6) and *Nr5a2^fl/fl^*;*Gnrhr^GRIC^*/+ (*Nr5a2*KO, n = 6) mice. Testicular (**C**) and seminal vesicle (**D**) weights were measured in 6 week-old male mice (control, n = 8; *Nr5a2*KO, n = 8, bars  =  means).

(TIF)

###### 

Click here for additional data file.

###### 

***Nr5a2*** **does not regulate gonadotrope expression of** ***Gnrhr in vitro*** **or** ***in vivo*** **. A**) LβT2 cells were transfected with 225 ng/well of the −1772/+38 murine *Gnrhr*-luc reporter. Cells were co-transfected with control, *Nr5a1* or *Nr5a2* siRNAs as indicated, at a final concentration of 5×10−9 M. Data represent the mean + SEM of four independent experiments performed in triplicate. **B**) cDNA was prepared from total RNA isolated from individual pituitary glands of *Nr5a2^fl/fl^* (control, n = 5) and *Nr5a2^fl/fl^*;*Gnrhr^GRIC^*/+ (*Nr5a2*KO, n = 8) male mice, and analyzed for expression of *Gnrhr* by quantitative real-time PCR.

(TIF)

###### 

Click here for additional data file.

###### 

**Primer sequences.**

(TIF)

###### 

Click here for additional data file.
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